Skip to main content
Clinical Trials/NCT04363710
NCT04363710CompletedNot Applicable

Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet

Max Healthcare Insititute Limited1 site in 1 country33 target enrollmentStarted: May 31, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
33
Locations
1
Primary Endpoint
Fasting Blood Glucose in millimoles per liter and Fasting Insulin Level in picomole per liter will be combined to report HOMA IR

Study Overview

Brief Summary

T2DM, a chronic progressive disorder has an epidemic status in India. Remission (HbA1c of < 6.5% without any anti-diabetic medication) of T2DM is achievable with diet modifications in recently diagnosed obese T2D individuals. Studies suggest Very Low Calorie Diet (600 - 800kcal) and Low Calorie Diet-LCD (800 -1000 kcal) using Meal replacers (MR) are helpful. The investigators aimed to study the effects of LCD without any anti diabetic medication in intervention group and later comparing it with Control group (on standard medical treatment).

Detailed Description

The objective is to study the effect of LCD in anthropometric , biochemical and NAFLD (Non Alcholic Fatty Liver Disease) parameters after 8 weeks and 24 weeks from enrollment.

Purposive sampling is used to enroll participants in the study. The LCD is a combination of one meal replacer and modified major meals. Calculated exchanges of food groups is taken care of in the other two major meals and snacks in between. Inorder to adhere compliance clinical (at baseline, after 8 weeks, after 24 weeks) as well as virtual visits through whatsapp, e-mails, SMS, phone calls (once a week during 8 weeks of intervention and further once a month upto 24 weeks) are scheduled. After 8 weeks of LCD, calorie is increased to 1200-1400 Kcal/day. In the control group the standard medical treatment is continued.

The data is collected in case report form and analysed using SPSS software by statistician.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
35 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with BMI ≥ 30 kg/m^2
  • •DM history of less than 6 years.
  • •HBA1C of 6.5-8.5 %.
  • •On two or less than two diabetes medication.

Exclusion Criteria

  • •Patients on Insulin
  • •Patients having any co morbidity like severe diabetic nephropathy, neuropathy and any other serious illness.
  • •Evidence of Type 1 diabetes, ketones and acidosis.

Arms & Interventions

Intervention group

Experimental

Participants in this arm were advised intervention of Low Calorie Diet (800-1000 Kcal/day) for 8 weeks without any anti diabetic medication

Intervention: Low Calorie Diet (Other)

Control Group

No Intervention

Participants in this arm were kept on their standard medical treatment

Outcomes

Primary Outcomes

Fasting Blood Glucose in millimoles per liter and Fasting Insulin Level in picomole per liter will be combined to report HOMA IR

Time Frame: up to 24 weeks

To achieve normal HOMA IR range

HbA1c in percentage

Time Frame: up to 24 weeks

To bring HbA1c below diagnostic criteria of type 2 diabetes mellitus as per ADA 2020

Weight in kilogram and height in meters will be combined to report BMI in Kg/m^2

Time Frame: up to 24 weeks

when obese T2D individuals will have significant improvement in BMI

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Max Healthcare Insititute Limited
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials